STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR

STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR

Introduction. The drugs affecting a mitochondrial dysfunction, oxidative stresses, apoptosis and inflammation of the vascular wall, have a high potential for the prevention and treatment of atherosclerotic lesions. In this regard, the use of EPOR/CD131 heteroreceptor agonists which have a similar sp...

Full description

Saved in:
Bibliographic Details
Main Authors: Olesya A. Puchenkova, Sergey V. Nadezhdin, Vladislav O. Soldatov, Maxim A. Zhuchenko, Diana S. Korshunova, Marina V. Kubekina, Evgeny N. Korshunov, Liliya V. Korokina, Polina A. Golubinskaya, Aleksandr L. Kulikov, Vladimir V. Gureev, Vladimir M. Pokrovskiy, Evgeniy A. Patrakhanov, Petr R. Lebedev, Tatyana A. Denisyuk, Veronika S. Belyaeva, Evgeniya A. Movchan, Elizaveta I. Lepetukha, Mikhail V. Pokrovskiy
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2020-10-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
atherosclerosis
erythropoietin derivatives
mitochondrial dysfunction
oxidative stress
Online Access:https://www.pharmpharm.ru/jour/article/view/687
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmpharm.ru/jour/article/view/687

Similar Items